Skip to main content
Fig. 3 | Diagnostic Pathology

Fig. 3

From: A first case report of clinical response to targeted therapy in a patient with primary myoepithelial carcinoma of the lung harboring EGFR exon 19 deletion

Fig. 3

Computed tomography scans of the patient showing the tumor responses to icotinib target therapy. a Scans at the baseline when diagnosed with primay myoepithelial carcinoma of the lung on Jul. 17, 2019 (tumor diameter of 6.2 cm × 4.7 cm). b Scans after icotinib regimen, with the tumor diameter of 4.2 cm × 3.5 cm and disease evaluated as PR on Sep. 07, 2019. c Scans during disease progression with tumor diameter of 4.8 cm × 4.7 cm on Oct. 07, 2019

Back to article page
\